Multi-specific antibodies and antibody combinations

The present invention relates to antibodies binding to IL13 and IL22. The invention provides novel multi-specific antibodies that bind to both IL13 and IL22 and compositions comprising an antibody that binds to IL13 and an antibody that binds to IL22. The invention further relates to therapeutic use...

Full description

Saved in:
Bibliographic Details
Main Authors SILVA, JOHN PAUL, CROSBY, ANDREA JULIE, LIGHTWOOD, DANIEL JOHN, ADAMS, RALPH, MAYANK, SEEMA, LEYSEN, SEPPE FRANS ROMAN, PALFRAMAN, ROGER THOMAS, TYSON, KERRY LOUISE, ELLIOTT, PETER CHARLES, RASTRICK, JOSEPH MICHAEL DAVID, AHDASH, ZAINAB, BARRY, EMILY MARY CAIRISTINE
Format Patent
LanguageChinese
English
Published 01.08.2022
Subjects
CHEMISTRY
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PEPTIDES
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Online AccessGet full text

Cover

More Information
Summary:The present invention relates to antibodies binding to IL13 and IL22. The invention provides novel multi-specific antibodies that bind to both IL13 and IL22 and compositions comprising an antibody that binds to IL13 and an antibody that binds to IL22. The invention further relates to therapeutic uses of the combination of anti-IL13 and anti-IL22 antibodies and multi-specific antibodies that bind to both IL13 and IL22.
Bibliography:Application Number: TW202110145573